Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
Good news is that profit margin > 20% for the two quarters, i.e. Jun'22 and Sep'22.
The first phase expansion plan is on track as well with the addition of beds. The board of directors are also confident and expecting a favorable year up until Jun'23. (The financial year runs from Jul'22 to Jun'23)
From just a high level view, no anomalies in the financial statements based on my view. Cash flow is good, expenses are as per expectation without sudden hike. With people getting more health conscious, it is going to be good for this company.
Been quiet for almost a year without any writing. This is my first company recommendation to myself after so long. Hope that the profit margin would maintain > 20% or best if can goes even higher in the next quarter.
Welcome all to discuss below! If you like my post, do follow me here, it gave me motivation to continue writing and sharing my ideas at here. Note that this is not buy/sell recommendation, you should do your own research, form your own view for any buy/sell action in the market. Thank you.
- The first phase expansion of the existing medical centre which includes an addition of 8 daycare beds
are fully operational in January 2023. This is to cater for the increasing demand of the Group's
medical services namely endoscopic procedures and surgeries.
- The current economic environment has resulted higher prices for our medical supplies which
incurred higher cost to our revenue. The Board of Directors will continue to assess and address the impact.
- After having considered the 6-month financial performance of the Group ended 31 December 2022
and the completion of the first phase expansion of the existing medical centre, the Board of
Directors expects the Group's prospects for the financial year ending 30 June 2023 to be favourable.
